| DC72546 |
Tri-GalNAc-NHS ester
|
Tri-GalNAc-NHS ester is a LYsosome TArgeting Chimera (LYTAC) and a ligand of asialoglycoprotein receptor (ASGPR). ASGPR is a lysosomal targeting receptor specifically expressed on liver cells, for the degradation of extracellular proteins including membrane proteins. Tri-GalNAc-NHS ester can be used as a protein degrader and it can be used for the research of LYTAC. |
| DC72426 |
DSPE-SPDP
|
DSPE-SPDP is a phospholipid molecule. DSPE-SPDP can orient itself to form lipid bilayer in water. DSPE-SPDP can be used for the research of various biochemical. |
| DC71044 |
Fluorescent DOTAP
|
Fluorescent DOTAP, a cationic lipid, can be used for the research of nucleic acid and protein delivery. |
| DC70010 |
98N12-5
|
98N12-5 is an ionizable cationic lipid. It has been used in combination with other lipids in the generation of lipid nanoparticles (LNPs). LNPs containing 98N12-5 and encapsulating proprotein convertase subtilisin kexin type 9 (PCSK9) siRNA selectively accumulate in the liver and reduce total serum cholesterol levels in mice and rats and serum LDL levels in cynomolgus monkeys. |
| DC49961 |
1-Palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt)
|
1-Palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) sodium salt is a lipid molecule having one negative charge, which can interact with the positive charges of peptides. |
| DC49882 |
CKK-E12
|
CKK-E12 is a ionizable lipid in combination with other lipids make up the lipid nanoparticles which are used to deliver RNA-based therapeutics. cKK-E12 was highly selective toward liver parenchymal cell in vivo.Multitail lipids usually have three or more tails and tend to form
more cone-shaped structures due to the increase of tail crosssection,
which enhances the endosome escape and mRNA
delivery efficiency.CKK-E12 is an ionizable lipid with four
lipid tails and diketopiperazine core-based head. It has shown
excellent efficiency in delivering CRISPR-Cas9 mRNA and
sgRNA.cKK-E12 iLNPs encapsulated mRNA was used to
investigate the effect of Toll-like receptor 4 (TLR4) on iLNPsmediated
mRNA delivery, and it has been demonstrated that
the targeting, safety and efficacy of iLNPs are closely related
to disease state. In other words, even though iLNP delivers
therapeutic mRNA to a given cell type in one disease state, it
is not guaranteed to deliver mRNA to the same cell type in
another disease. As same as MC3 and C12-200, CKK-E12 is also
used to be a positive control ionizable lipid when exploiting new
ionizable lipids. |
| DC49249 |
DOPS-NA
|
DOPS-NA is a ubstitute for Phosphoserine/phosphatidylserine. DOPS-NA can be used in lipid mixtures with DOPC and DOPE as effective nontoxic and nonviral DNA vectors. |
| DC49239 |
18:0 DAP
|
18:0 DAP can be used to formulate lipid nanoparticles (LNPs), which mRNA is encapsulated in their core. |
| DC47310 |
Rovanersen
|
Rovanersen (WVE-120101) is an antisense oligonucleotide that can be used for huntington’s disease research. |
| DC47285 |
Tofersen
|
Tofersen (BIIB067) is an antisense oligonucleotide that mediates RNase H-dependent degradation of superoxide dismutase 1 (SOD1) mRNA to reduce the synthesis of SOD1 protein. Tofersen can be used for the research of amyotrophic lateral sclerosis (ALS). |
